Biotechnology from bench to business

• Follow GEN on:
• Log In / Register | Subscribe

Current Issue

Top Keywords

• ADME/Tox
• Angiogenesis
• Apoptosis
• Antibodies
• Biomanufacturing
• Biomarkers
• Bioreactors
• Biosimilars
• Biotherapeutics
• Cancer
• Cancer Stem Cells
• Cell Culture
• Cell-Based Assays
• Chromatography
• Contract Manufacturing
• Gene Expression
• Genetics
• Genomics
• Glycan Analysis
• HPLC
• Immunoassay
• Liquid Handling
• mAb Production
• mAb Therapeutics
• Microarrays
• Multiplexing
• Next-Generation Sequencing
• Peptide Therapeutics
• PCR
• Pharmacokinetics
• Protein Characterization
• Protein Expression
• Protein Production
• Protein Therapeutics
• qPCR
• Reagents
• RNA-Seq
• Sequencing
• Single-Use Systems
• Small Molecules
• Stem Cells
• Transfection
• Vaccines

Life Technologies - Related Content

• GEN Articles
• Insight & Intelligence™
• GEN News Highlights
• New Products

GEN articles

• Sidebars: Royalty-Free Kits for Drug Production Unveiled at “ESACT”
  
• Tutorials: Next-Generation DNA Assembly Tools
  Emergence of Synthetic Biology Necessitates New Solutions to Generate Molecules
• Tech Notes: Novel Vectors for Baculovirus Expression
  Gene Cloning and Protein Expression in Insect Cells Is Faciliatated by New Methodologies
• Assay Tutorials: Simplification of Kinase Binding Assays
  TR-FRET Tools Broaden the Potential of Drug Screening
• Sidebars: Beijing Institute of Genomics Expands Applications for Life Technologies’ SOLiD System
  

• MORE LIFE TECHNOLOGIES RELATED GEN ARTICLES

Insight & intelligence™

• Filings Postponed in Promega v. Life Tech as Parties Try to Settle
  March 15, 2012
  Last month a jury awarded Promega $52 million in damages related to firm’s short tandem repeat technology.
• Sequencing in the Dark
  March 1, 2012
  Analysis of Life Technologies’ Ion Torrent sequencing platform points to significance of photon-free technology.
• Enzo Sues Roche, Gen-Probe, and Life Technologies in Patent Infringement Case
  February 29, 2012
  Patent under dispute expires in 2023, and defendants plan on fighting the lawsuit.
• Sequencing Firms Set Up Centers to Advance Genomics Research and Instrument Sales
  February 20, 2012
  Strategy provides a feedback loop to improve instrumentation and develop new applications.
• R&D Direction in 2012 for Sequencing Technologies Is Aimed at Clinical Medicine
  January 5, 2012
  Companies are focused on making these platforms smaller and easier to use.

• MORE LIFE TECHNOLOGIES RELATED INSIGHT & INTELLIGENCE™

GEN news highlights

• Life Technologies Pledges $20M to Expand Cell Culture Capacity at Scottish Site
  
• Ingenuity, Life Tech Introduce Solution for Real-Time PCR Gene-Expression Analysis
  
• Life Technologies, DaAn Establish Chinese Diagnostics Joint Venture
  
• Ion Torrent Instrument Designed to Sequence the Human Genome for $1,000 in One Day
  
• Life Technologies to Develop Companion Diagnostic for GSK’s Cancer Immunotherapy
  

• MORE LIFE TECHNOLOGIES RELATED GEN NEWS HIGHLIGHTS

New products

	Life Technologies Stem Cell Culture Medium StemPro® MSC SFM liquid stem cell culture medium is intended for human ex vivo tissue and cell culture. It is designed to efficiently grow large amounts of human mesenchymal stem cells (MSCs) while maintaining their undifferentiated state. As an
	Life Technologies Cell-Line Development Kits Gibco® Freedom™ cell-line development kits are a new line of products that integrate cells, reagents, culture media, and protocols. The Freedom CHO-S™ kit, developed in collaboration with ProBioGen, and the DG44 kit provide component
	Life Technologies Lyophilized Gene-Expression Assays Lyophilized TaqMan® gene-expression assays with master mix is a mixture of TaqMan probe, primers, and master mix delivered in eight-well strip-tubes. Designed to simplify the qPCR experimental workflow, Lyophilized TaqMan assays with master mix
	Life Technologies iPSC Generation CytoTune™-iPS reprogramming kit is used for developing induced pluripotent stem cells from human somatic cells. The CytoTune kit is based on zero-footprint technology that employs an RNA virus developed by DNAvec. The benign vectors are effect
	Life Technologies Histone Cellular Assay Kits BacMam Histone Cellular Assay Kits allow researchers to choose the histone modification that corresponds to their enzyme of interest in their preferred cell background. The researcher’s cell line of interest is transduced with BacMam

• MORE LIFE TECHNOLOGIES RELATED NEW PRODUCTS

Home | Terms of Use | Privacy Statement | Legal